145 related articles for article (PubMed ID: 32505664)
1. Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology study.
Liang Y; Zhou R; Liang X; Kong X; Yang B
Eur J Pharmacol; 2020 Aug; 881():173227. PubMed ID: 32505664
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses.
Li R; Song Y; Ji Z; Li L; Zhou L
Biofactors; 2020 Jan; 46(1):158-167. PubMed ID: 31647596
[TBL] [Abstract][Full Text] [Related]
3. Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks.
Li J; Guo C; Lu X; Tan W
Eur J Pharmacol; 2019 Sep; 858():172483. PubMed ID: 31233753
[TBL] [Abstract][Full Text] [Related]
4. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach.
Huang C; Li R; Shi W; Huang Z
Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Plumbagin on Pancreatic Cancer: A Mechanistic Network Pharmacology Approach.
Pan Q; Zhou R; Su M; Li R
Med Sci Monit; 2019 Jun; 25():4648-4654. PubMed ID: 31230062
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma.
Zhou R; Wu K; Su M; Li R
Environ Toxicol Pharmacol; 2019 Aug; 70():103200. PubMed ID: 31158732
[TBL] [Abstract][Full Text] [Related]
7. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
[TBL] [Abstract][Full Text] [Related]
8. Anti-Colorectal Cancer Mechanisms of Formononetin Identified by Network Pharmacological Approach.
Zhang L; Gong Y; Wang S; Gao F
Med Sci Monit; 2019 Oct; 25():7709-7714. PubMed ID: 31608899
[TBL] [Abstract][Full Text] [Related]
9. Integrative findings indicate anti-tumor biotargets and molecular mechanisms of calycosin against osteosarcoma.
Tan J; Qin X; Liu B; Mo H; Wu Z; Yuan Z
Biomed Pharmacother; 2020 Jun; 126():110096. PubMed ID: 32179199
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats.
Wang Y; Jin HY; Fang MZ; Wang XF; Chen H; Huang SL; Kong DS; Li M; Zhang X; Sun Y; Wang SM
World J Gastroenterol; 2020 May; 26(17):2064-2081. PubMed ID: 32536775
[TBL] [Abstract][Full Text] [Related]
12. Integration of genetic variants and gene network for drug repurposing in colorectal cancer.
Irham LM; Wong HS; Chou WH; Adikusuma W; Mugiyanto E; Huang WC; Chang WC
Pharmacol Res; 2020 Nov; 161():105203. PubMed ID: 32950641
[TBL] [Abstract][Full Text] [Related]
13. Scutellaria Barbata D Don Inhibits Colorectal Cancer Growth via Suppression of Multiple Signaling Pathways.
Lin J; Chen Y; Cai Q; Wei L; Zhan Y; Shen A; Sferra TJ; Peng J
Integr Cancer Ther; 2014 May; 13(3):240-8. PubMed ID: 24231788
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of colorectal cancer patients and anti-neoplasm activity of genistein.
Chen X; Gu J; Wu Y; Liang P; Shen M; Xi J; Qin J
Biomed Pharmacother; 2020 Apr; 124():109835. PubMed ID: 31958764
[TBL] [Abstract][Full Text] [Related]
15. Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1.
Kobelt D; Zhang C; Clayton-Lucey IA; Glauben R; Voss C; Siegmund B; Stein U
Front Immunol; 2020; 11():980. PubMed ID: 32670264
[TBL] [Abstract][Full Text] [Related]
16. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling.
Yang X; Zou J; Cai H; Huang X; Yang X; Guo D; Cao Y
Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725
[TBL] [Abstract][Full Text] [Related]
18. Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: Analyses of network pharmacology, human and experimental data.
Li R; Ma X; Song Y; Zhang Y; Xiong W; Li L; Zhou L
J Cell Biochem; 2019 Jul; 120(7):11265-11273. PubMed ID: 30719773
[TBL] [Abstract][Full Text] [Related]
19. MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.
Chen E; Li Q; Wang H; Yang F; Min L; Yang J
Biomed Pharmacother; 2018 Oct; 106():1370-1377. PubMed ID: 30119209
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.
Yu C; Hong H; Lu J; Zhao X; Hu W; Zhang S; Zong Y; Mao Z; Li J; Wang M; Feng B; Sun J; Zheng M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806905. PubMed ID: 30336768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
